Answered You can buy a ready-made answer or pick a professional tutor to order an original one.
Discuss pap-smear as a diagnostic tool description of how pap smear is used in healthcare. Based on your research, evaluate the test or the tool’s validity and reliability, and explain any issues with
Discuss pap-smear as a diagnostic tool
description of how pap smear is used in healthcare.
Based on your research, evaluate the test or the tool’s validity and reliability, and explain any issues with sensitivity, reliability, and predictive values. Include references not more than 5 years in appropriate APA formatting.
- @
- 1030 orders completed
- ANSWER
-
Tutor has posted answer for $23.00. See answer's preview
***** Smear **************************************************** ***** ******* *** smear test ** used ** ******** ********** ** *** ****** ** ** ******** ********** ** detect ********* ** ************ **** ** *** cervix **** *** ***** ***** are **** ********* ** determine *** ********** Papanicolaou ***** ** *** ***** tests *** ***** ***** ****** ****** ************ *** pioneered **** ******** ***** ***** ** ** * *********** *********** ** *** ***** **** *** obtained from the *********** ****** ** is * ***** **** for many ***** ***** ******** ****** ** the fourth leading type ** cancer ** women *** ***** ***** lead to *** early ********* *** intervention ** ******** cancer cases ** is * *********** **** ***** cervical ****** ***** ** ******* ** **** women that do not ******* the symptoms *** ***** **** been ********** ** the ****** ******* ** *** deaths ********** **** ******** ****** Abnormal *** ***** ***** are indicative of *** early stages of ****** *** are ******** **** ********** *********** from *** doctorSince *** **** ** ****** it ** ******* ******* ** ***** *********** **** have * **** **** of contracting ******** cancer ****** **** a **** **** ** *********** the human papillomavirus *** also ** * **** **** of ****** ******** ****** **** ******* include ****** ******** sexual ******** ***** ******** ****** ** ** ***** *** **** immunes ******* ******* *** * history ** ****** ** *** ***** genital tract ******** ****** ********* ** *********** ***** ***** ***** for ***** ***** ********** years ******* pap ********** *** usually ** ***** ********** **** conducting *** *** smear ***** * *********** **** **** *** ******** is the ******* to ****** ********* ****** ***** *** ***** early ************ The ******** ** *** ***** ***** will depend ** ******** preparations ** *** part ** *** patient *** a ***** ***** ********* ** take *** tests ****** *** ** ** when ************ It ** ******* ********* ** ***** ******* ********** *** days before *********** *** ****** ********* ** ***** ********** often makes ** ********* *** ******* to ********* *** ******** of *** test The ********** ******* ******* *********** ******* ************** *** vaginal *********** Vaginal *********** *** **** avoided ** ** *** direction ** *** *********** ******* ********** ************ ** the *** **** ******** full pap smear tests which **** involve * pelvic exam ** **** as a breast **** Pap smear ***** will ***** under a minute ***** *** completion of *** ****** and ****** ***** * typical ***** *** the test **** involve * ***** ***** ** *** back **** *** ***** ** *** also *** ** ** **** **** *** **** ** ******** *** ********** ******** **** **** use * ******** ** **** *** ****** *** speculum ** * small plastic or ***** instrument **** opens *** ****** *** *** ***** ********** ** the ****** Under ****** circumstances the **** is *** ******* and ******* ******* **** **** *** *********** ************* **** step ** *** *** healthcare provider ** ****** ******** ***** *** mucus **** *** ****** *** ********** **** ** done using a cervical ***** ******** ***** ** ****** ******* *** sample cells *** placed ** * glass ***** ***** ** **** ******* **** * ******** A modern *********** ** ** ***** *** ****** cells ** * **** ** a ******* ****** *** ********* **** ** ** * ********** *** will look at *** ***** through * ********** to determine *** ******** of *** ****** ******** ** reasonable **** outcome ********* that the ****** is ******* The ***** is ******* when *** ********** ********** that all *** cells in *** ****** are robust ** ***** ** **** *** ***** * ******** ** ******** ****** ********* that the ****** ** *** ******* **** ******** *** ***** **** *** *********** spot ******** ***** **** are ** ********* size and ***** Abnormality ** *** sample ** *** ** indication of the ******** of cancer in *** **** ********* *** ***** ***** be shaped ********** *** *** *** cancerous ********* ***** ***** ***** ***** chlamydia and ***** ********** ** * cellular ***** ***** *** ******** cells to inflame ***** the abnormality Treating the ********** ***** of positive ** abnormal results ****** have *** ***** ******* when *** *** ***** **** is ******** *** ****** ****** **** *** ******** ****** ** report *** interpret *** ******* of *** tests The ******** ****** ********** the criteria for abnormalities *** ********** *** ******* ***** as having negative ************* ***** **** is ****** **** for screening ******** *** not ** a ********* process *** test ** *** **** ******** ** ********** the presence ** ********* cells Some ********** of abnormalities ******* ** ********** **** *** **** ** **** *** ****** ********** ******** ** *** ** *** *********** *********** ** *** **** *** ***** ****** ** *** smear ** *** * ******** ********** of *** ***** ****** (Schan et ** ***** ** ** ** **** *********** ** collect * **** ****** **** ** ************** of the ****** ****** and vagina ***** *** need *** ******** *** ***** ******** *** smear test ** ********* sensitive to ***** which ******* digitalis *** ************ ** ** ******** to ****** wrong ******* **** ********* **** have * longer-lasting ****** ** *** **** *** ********** ** ********** ******** ******* *********** *** ******** *** *********** ** the **** *** **** ** ** times unreliable since ** might **** ** ******** ******** ***** **** *** ******* ** ******** abnormal cells **** are not present It is ********* recommended ** **** ******** ***** ** ******** *** ******* ********************************** K ***** Doane * * (2017) ************ ******* of the *** Smear Belief Questionnaire: ********* ********* ********* *** ******* ****** ******** ****** Screening ******* ** nursing *********** ***** 77-89Sachan P L ***** M ***** M * ***** ****** * ****** A ***** ** ******** ****** screening ***** *** smear **** *** clinical *********** Asia-Pacific ******* of ******** ******* 5(3) 337Syed * ****** A Survey ** ******** Cancer and *** Smear ********* *** *********** ** *** smear **** among ****** ****** **** providers in * Secondary **** ******** Pakistan ******* ** *** ******* ** ********** *** ************** ** Pakistan **** *********